Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26Q2, 26 TTM Selling/general/admin expenses 7 M5 M5 M5 M8 M3 M 21 M Research & development —————— — Operating income 92 M82 M102 M116 M81 M136 M 435 M Non-Operating Income, Total 1 M0-3 M1 M8 M0 6 M Interest expense, net of interest capitalized 119 M117 M121 M120 M118 M117 M 476 M Non-Operating Income, excl. Interest Expenses -119 M-117 M-121 M-120 M-118 M-117 M -476 M Unusual income/expense 1 M0-3 M1 M8 M0 6 M Pretax income -24 M-35 M-28 M-26 M-28 M19 M -63 M Equity in earnings —————— — Taxes -15 M21 M-18 M-16 M-8 M5 M -37 M Non-controlling/minority interest —————— — After tax other income/expense -4 M-3 M-4 M-4 M-1 M1 M -8 M Net income before discontinued operations -9 M-56 M-10 M-10 M-20 M14 M -26 M Discontinued operations —————— — Net income -9 M-56 M-10 M-10 M-20 M14 M -26 M Dilution adjustment 000000 0 Preferred dividends 13 M13 M13 M13 M13 M-7 M 32 M Diluted net income available to common stockholders -22 M-69 M-23 M-23 M-33 M21 M -58 M Basic earnings per share (Basic EPS) -0.23-0.71-0.24-0.23-0.340.21 -0.6 Diluted earnings per share (Diluted EPS) -0.23-0.71-0.24-0.23-0.340.21 -0.6 Average basic shares outstanding 96 M97 M97 M97 M97 M98 M — Diluted shares outstanding 96 M97 M97 M97 M97 M100 M — EBITDA 129 M175 M162 M258 M146 M191 M 757 M EBIT 92 M82 M102 M116 M81 M136 M 435 M Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 37 M93 M60 M142 M65 M55 M 322 M